期刊
BLOOD
卷 114, 期 19, 页码 4158-4168出版社
AMER SOC HEMATOLOGY
DOI: 10.1182/blood-2008-12-192583
关键词
-
类别
资金
- Intramural Research Program of the National Institutes of Health
- National Institute of Allergy and Infectious Diseases
- National Cancer Institute [R01 CA87064]
- Cancer Center [CA21765]
- American Lebanese Syrian Associated Charities (ALSAC)
- St Jude Children's Research Hospital
BCL10, required for nuclear factor kappa B (NF-kappa B) activation during antigen-driven lymphocyte responses, is aberrantly expressed in mucosa-associated lymphoid tissue-type marginal zone (MZ) lymphomas because of chromosomal translocations. E mu-driven human BCL10 transgenic (Tg) mice, which we created and characterize here, had expanded populations of MZ B cells and reduced follicular and B1a cells. Splenic B cells from Tg mice exhibited constitutive activation of both canonical and noncanonical NF-kappa B signaling pathways is associated with increased expression of NF-kappa B target genes. These genes included Tnfsf13b, which encodes the B-cell activating factor (BAFF). In addition, levels of BAFF were significantly increased in sera from Tg mice. MZ B cells of Tg mice exhibited reduced turnover in vivo and enhanced survival in vitro, indicative of lymphoaccumulation rather than lymphoproliferation as the cause of MZ expansion. In vivo antibody responses to both T-independent, and especially T-dependent, antigens were significantly reduced in Tg mice. Mortality was accelerated in Tg animals, and some mice older than 8 months had histologic and molecular findings indicative of clonal splenic MZ lymphoma. These results suggest that, in addition to constitutive activation of BCL10 in MZ B cells, other genetic factors or environmental influences are required for short latency oncogenic transformation. (Blood. 2009; 114:4158-4168)
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据